Shenzhen Witleaf Medical Electronics Co., Ltd.'s self-developed blood oxygen monitoring equipment has initiated a rigorous and scientific blood oxygen clinical trial project at the International Hypoxemia Laboratory (HLSZU) of Shenzhen University General Hospital.

In the clinical trial, Witleaf's cutting-edge blood oxygen devices will be benchmarked against the gold standard of blood gas analysis for meticulous comparative testing. The aim is to verify and enhance the precision and reliability of Vitroly's devices by rigorously comparing their readings to blood gas analysis results, ultimately providing clinicians with a more accurate and efficient tool for monitoring blood oxygen saturation levels.

Witleaf Medical consistently prioritizes technological innovation as its core driving force, focusing on developing high-quality medical devices. The development and optimization of its blood oxygen detection equipment are grounded in robust clinical research, aiming to test and refine the products through practical application and driven by clinical needs, thereby continuously enhancing product performance and service quality.